Track Achieve Life Sciences, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Achieve Life Sciences, Inc. ACHV Open Achieve Life Sciences, Inc. in new tab

4.77 USD
EPS
-1.07
P/B
28.95
ROE
-496.15
Beta
2.25
Target Price
14.63 USD
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateAug. 6, 2026
EPS-1.07
Book Value0.20
Price to Book28.95
Debt/Equity140.03
% Insiders0.930%
Estimates
Forward P/E-8.25
Forward EPS-0.70
Target Mean Price14.63

DCF Valuation

Tweak assumptions to recompute fair value for Achieve Life Sciences, Inc. (ACHV)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Achieve Life Sciences, Inc. Logo Achieve Life Sciences, Inc. Analysis (ACHV)

Canada Health Care Official Website Stock

Is Achieve Life Sciences, Inc. a good investment? Achieve Life Sciences, Inc. (ACHV) is currently trading at 4.77 USD. Market analysts have a consensus price target of 14.63 USD. This suggests a potential upside from current levels.

Earnings Schedule: Achieve Life Sciences, Inc. is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is -0.70.

Investor FAQ

Does Achieve Life Sciences, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Achieve Life Sciences, Inc.?

Achieve Life Sciences, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of -1.07.

Company Profile

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Exchange Ticker
NMS (United States) ACHV
FRA (Germany) SP4P.F

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
July 31, 2020 0.050000
May 24, 2018 0.100000
Aug. 3, 2017 0.090000
Aug. 21, 2008 0.060000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion